# Evalve

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evalve

- Industry: Medical Devices & Equipment
- Headquarters: Menlo Park, US
- Total disclosed funding: $95M
- Latest round: Series D (Nov 6, 2007)
- Investors on record: 10

## About

Established in 1999 and based in California, US, Evalve, Inc. manufactures medical devices for the repair of cardiac valves.

## Funding rounds

- Series D, Nov 6, 2007, $60M — Delphi Ventures, New Enterprise Associates, Split Rock Partners, Abbott Laboratories, Sterling Capital Funds
- Series C, May 24, 2004, $35M — Delphi Ventures, New Enterprise Associates, ABS Ventures, Three Arch Partners, St. Paul Venture Capital, Cutlass Capital, Guidant Corp.
- Seed, Jun 1, 1999 — New Enterprise Associates

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Seed, Series C, Series D
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series C, Series D
- ABS Ventures (https://capitalatlas.ai/funds/abs-ventures) — Series C
- Three Arch Partners (https://capitalatlas.ai/funds/three-arch-partners) — Series C
- St. Paul Venture Capital (https://capitalatlas.ai/funds/st-paul-venture-capital) — Series C
- Cutlass Capital (https://capitalatlas.ai/funds/cutlass-capital) — Series C
- Guidant Corp. — Series C
- Split Rock Partners (https://capitalatlas.ai/funds/split-rock-partners) — Series D
- Abbott Laboratories — Series D
- Sterling Capital Funds — Series D